CJ HealthCare Corp. - Product Pipeline Review - 2016

  • ID: 3845372
  • Company Profile
  • 58 pages
  • Global Markets Direct
1 of 4
CJ HealthCare Corp. - Product Pipeline Review - 2016

Summary

‘CJ HealthCare Corp. - Product Pipeline Review - 2016’, provides an overview of the CJ HealthCare Corp.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by CJ HealthCare Corp., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of CJ HealthCare Corp.
- The report provides overview of CJ HealthCare Corp. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses CJ HealthCare Corp.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features CJ HealthCare Corp.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate CJ HealthCare Corp.’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for CJ HealthCare Corp.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding CJ HealthCare Corp.’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Tables

List of Figures

CJ HealthCare Corp. Snapshot

CJ HealthCare Corp. Overview

Key Information

Key Facts

CJ HealthCare Corp. - Research and Development Overview

Key Therapeutic Areas

CJ HealthCare Corp. - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Pipeline Products - Combination Treatment Modalities

Pipeline Products - Partnered Products

Partnered Products/Combination Treatment Modalities

CJ HealthCare Corp. - Pipeline Products Glance

CJ HealthCare Corp. - Late Stage Pipeline Products

Pre-Registration Products/Combination Treatment Modalities

Phase III Products/Combination Treatment Modalities

CJ HealthCare Corp. - Clinical Stage Pipeline Products

Phase II Products/Combination Treatment Modalities

Phase I Products/Combination Treatment Modalities

CJ HealthCare Corp. - Early Stage Pipeline Products

IND/CTA Filed Products/Combination Treatment Modalities

Preclinical Products/Combination Treatment Modalities

Discovery Products/Combination Treatment Modalities

CJ HealthCare Corp. - Drug Profiles

(ezetimibe + rosuvastatin calcium)

Product Description

Mechanism of Action

R&D Progress

(amlodipine besylate + candesartan cilexetil)

Product Description

Mechanism of Action

R&D Progress

(amlodipine besylate + rosuvastatin calcium + valsartan)

Product Description

Mechanism of Action

R&D Progress

(atorvastatin calcium + metformin hydrochloride) XR

Product Description

Mechanism of Action

R&D Progress

tegoprazan

Product Description

Mechanism of Action

R&D Progress

CJ-40006

Product Description

Mechanism of Action

R&D Progress

darbepoetin alfa

Product Description

Mechanism of Action

R&D Progress

(amlodipine besylate + atorvastatin calcium + valsartan)

Product Description

Mechanism of Action

R&D Progress

somatropin biobetter

Product Description

Mechanism of Action

R&D Progress

NSI-566

Product Description

Mechanism of Action

R&D Progress

CJ-14199

Product Description

Mechanism of Action

R&D Progress

CJ-40010

Product Description

Mechanism of Action

R&D Progress

CJ-40011

Product Description

Mechanism of Action

R&D Progress

RQ-00000010

Product Description

Mechanism of Action

R&D Progress

RQ-00000774

Product Description

Mechanism of Action

R&D Progress

Small Molecules to Inhibit Janus Kinase for Rheumatoid Arthritis

Product Description

Mechanism of Action

R&D Progress

ranibizumab biosimilar

Product Description

Mechanism of Action

R&D Progress

CJ HealthCare Corp. - Pipeline Analysis

CJ HealthCare Corp. - Pipeline Products by Target

CJ HealthCare Corp. - Pipeline Products by Route of Administration

CJ HealthCare Corp. - Pipeline Products by Molecule Type

CJ HealthCare Corp. - Pipeline Products by Mechanism of Action

CJ HealthCare Corp. - Recent Pipeline Updates

CJ HealthCare Corp. - Dormant Projects

CJ HealthCare Corp. - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

CJ HealthCare Corp., Key Information

CJ HealthCare Corp., Key Facts

CJ HealthCare Corp. - Pipeline by Indication, 2016

CJ HealthCare Corp. - Pipeline by Stage of Development, 2016

CJ HealthCare Corp. - Monotherapy Products in Pipeline, 2016

CJ HealthCare Corp. - Combination Treatment Modalities in Pipeline, 2016

CJ HealthCare Corp. - Partnered Products in Pipeline, 2016

CJ HealthCare Corp. - Partnered Products/ Combination Treatment Modalities, 2016

CJ HealthCare Corp. - Pre-Registration, 2016

CJ HealthCare Corp. - Phase III, 2016

CJ HealthCare Corp. - Phase II, 2016

CJ HealthCare Corp. - Phase I, 2016

CJ HealthCare Corp. - IND/CTA Filed, 2016

CJ HealthCare Corp. - Preclinical, 2016

CJ HealthCare Corp. - Discovery, 2016

CJ HealthCare Corp. - Pipeline by Target, 2016

CJ HealthCare Corp. - Pipeline by Route of Administration, 2016

CJ HealthCare Corp. - Pipeline by Molecule Type, 2016

CJ HealthCare Corp. - Pipeline Products by Mechanism of Action, 2016

CJ HealthCare Corp. - Recent Pipeline Updates, 2016

CJ HealthCare Corp. - Dormant Developmental Projects,2016

CJ HealthCare Corp., Other Locations 56List of Figures

CJ HealthCare Corp. - Pipeline by Top 10 Indication, 2016

CJ HealthCare Corp. - Pipeline by Stage of Development, 2016

CJ HealthCare Corp. - Monotherapy Products in Pipeline, 2016

CJ HealthCare Corp. - Combination Treatment Modalities in Pipeline, 2016

CJ HealthCare Corp. - Partnered Products in Pipeline, 2016

CJ HealthCare Corp. - Pipeline by Top 10 Target, 2016

CJ HealthCare Corp. - Pipeline by Route of Administration, 2016

CJ HealthCare Corp. - Pipeline by Molecule Type, 2016

CJ HealthCare Corp. - Pipeline Products by Top 10 Mechanism of Action, 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll